《半日总结》恒指涨170点 汇控弹逾7%重上30元 恒大回升12%
港股在汇控(00005.HK)引领下反覆向上。美股上周五(25日)全线造好。恒指今早高开48点後，一度升幅收窄至14点曾低见23,250，其後发力最多升186点曾高见23,421。恒指半日升170点或0.7%，收23,406点；国指升50点或0.6%，报9,353点；恒生科技指数半日升24点或0.4%，报6,943点。大市半日成交总额494.73亿元。
中国平安(02318.HK)上周三斥3.05亿元增持汇控，令持股量升至8%，中国平安股价跌0.4收80.05元，汇控早市股价上扬7.8%30.4元，单股为恒指贡献125点升幅。
国寿(02628.HK)增持并举牌工行(01398.HK)H股，持股升至5.02%，两股股价分别升0.1%及0.8%。港交所(00388.HK)、友邦(01299.HK)分别升1.4%、跌0.8%。
市传美国对中芯(00981.HK)采出口限制，中芯指未收到官方消息，惟股价低开低走，半日跌5.8%收17.5元。腾讯(00700.HK)升0.2%，报504.5元。阿里巴巴(09988.HK)升2.2%，报263.6元。美团(03690.HK)、小米(01810.HK)分别升2.2%及2.4%。京东(09618.HK)公布京东健康已递交上市申请表格，股价升2.5%。
中资电讯股受压，联通(00762.HK)跌3.4%，中电信(00728.HK)、中移动(00941.HK)分别跌1.3%及1.2%。
中国恒大(03333.HK)重申经营正常，有关分拆旗下的物业管理业务已获联交所批准，早市股价扬11.9%。恒大系恒大汽车(00708.HK)、恒腾网络(00136.HK)各回升14.9%及7.8%。
内房股回稳，万科(02202.HK)升逾半成。碧桂园(02007.HK)、润地(01109.HK)分别升1%及0.7%。航空股回升，国泰(00293.HK)升4.2%。国航(00753.HK)、东航(00670.HK)、南航(01055.HK)升1.6%-4.3%。
光伏玻璃股续升，福莱特玻璃(06865.HK)、信义光能(00968.HK)分别弹5.5%及4.3%。
摩根士丹利将复星国际(00656.HK)评级上调至「增持」，复星国际股价升1.3%。复星医药(02196.HK)则跌2.3%。开拓药业(09939.HK)计划於明年上半年提交普克鲁胺之新药申请，痤疮临床试验获中国国家药监局批准，惟股价逆市下挫，半日急11.2%，报9.41元。
人和科技(08140.HK)股价突然暴泻，最低见过0.146元泻逾九成，股价半日泻87.6%，报2.03元。
再鼎医药(09688.HK)今早首挂，半日报607.5元，较招股价562元升8.1%。上市翌日的明源云(00909.HK)股价回落，半日挫8.6%报28.05元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
